1. Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma. (3rd November 2015) Authors: Ouerdani, A; Struemper, H; Suttle, AB; Ouellet, D; Ribba, B Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 4:Number 11(2015:Nov.) Page Start: 660 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗